The association between aggregates of leucocytes in blood drawn from patients with various inflammatory conditions and the serum concentration of C-reactive protein (CRP) was examined: serum concentration of CRP might contribute to the development of cellular aggregations. A total of 213 patients with various inflammatory or necrotic conditions were examined (including 31 women with normal pregnancy and 59 controls). A significant correlation between the degree of leucocyte aggregation and CRP concentration was noted in patients with bacterial infections and in a group of patients with various inflammatory conditions. In contrast, there was no correlation between the extent of leucocyte aggregation and CRP concentrations in patients with viral infections, malignancies, or pregnancy. The presence or absence of aggregated leucocytes can help in differentiating between the respective bacterial or viral infections. The serum concentrations of CRP were increased in both types of infection, although when a quantitative CRP assay was used, considerably higher concentrations were detected in bacterial diseases.
For at least 40 years it has been known that leucocytes aggregate during various inflammatory conditions,' although the mechanism for this process has been postulated only recently.2 It has been shown that aggregation may have deleterious pathophysiological consequences in various conditions, including extracorporeal circulation,3 4 states of shock, and myocardial infarction5 and during transfusion of granulocytes.6 It has been proposed that aggregated leucocytes stick to the pulmonary capillaries, leading to endothelial damage and the development of the adult respiratory distress syndrome. 7 The research on leucocyte aggregation has been intensified by the idea of using an in vitro neutrophil aggregation activity test, allowing plasma or serum from patients with various inflammatory conditions to act on purified leucocytes drawn from a normal donor in a platelet aggregometer.8 This test, however, has been variously criticised: the correlation of the assay with clinical conditions has not been clearly shown as yet9; the changes in light transmission recorded by the platelet aggregometer might not reflect changes in the aggregation state of the Accepted for publication 17 June 1986 leucocytes'0; leucocytes from patients might be more reactive to aggregating stimuli than the normal blood donor's leucocytes"; the assay requires fresh sources of leucocytes, thus using different donors, a fact that might complicate standardisation.
For these reasons we recently suggested that, for clinical purposes, the leukergy test might be used instead, The leukergy test, originally described by Ludwik Fleck,' consists of observing aggregated leucocytes in the peripheral blood under inflammatory conditions. We recently modified this into a simple rapid and convenient test12 and were able to show its superiority over the neutrophil aggregation activity test (performed in the platelet aggregometer) under various clinical conditions.'3 14 Aggregation of leucocytes, as indicated by the leukergy test described below, is a non-specific marker of inflammation. We thought it would be useful to study its relation to another non-specific marker of the acute phase reaction-that is, C-reactive protein (CRP). The purpose of the present study was to try to obtain answers to the following questions: 1 Is the aggregation of leucocytes an integral part of the acute phase reaction, of which CRP is a classical ); lower urinary tract infection (n = 10); cellulitis or erysipelas (n = 15). In the group with viral infections there were patients with upper respiratory infections (n = 36); measles (n = 11); infectious mononucleosis (n = 6); hepatitis (n = 5); meningitis (n = 5); mumps (n = 3); herpes zoster (n = 1) and rubella (n = 1). The groups designated as "various diseases" included patients with exacerbation of chronic obstructive pulmonary disease (n = 27), cerebrovascular accidents (n = 5), and myocardial infarctions (n = 5). The group with malignancies included patients with various carcinomas (breast, colon, ovary) in advanced stages. The group with collagen diseases comprised four patients with rheumatoid arthritis, four with systemic lupus erythematosus, and three with various non-defined arthritides. 
Discussion
In the present study the correlations between the degree of leucocyte aggregation, as indicated by the Berliner, Caspi. Newnan, Ostfeld, Hod, Yaron, Pinkhas, Aronson leukergy test, and CRP estimates were studied in patients with various inflammatory conditions. The leukergy phenomenon, originally described by Ludwik Fleck in the mid 20th century is a nonspecific marker of inflammation. This is confirmed by the variety of inflammatory processes in which positive leukergy has been described-that is, infections, burns, immunisations, sterile inflammations, convulsions, trauma, rheumatic diseases and infarctions.1 12 -14 23 As many of these conditions are characterised by an increase in the serum concentrations of CRP`5 16 we were interested in the examination of both variables to verify whether the two phenomena are interrelated. It seems that in some inflammatory conditions leukergy and CRP are, indeed, significantly correlated, while in the others they are not. The tentative conclusion is that increased concentrations of CRP are not needed for the induction or the presence of the leukergy phenomenon. As it has been suggested that C-reactive protein might contribute to the development of cellular aggregations16 17 the results of the present study are important because they show that the leucocyte aggregation in patients with various inflammatory conditions (indicated by the leukergy test) is not necessarily associated with increased CRP concentrations. The two phenomena may reflect separate aspects of the inflammatory process.
The leukergy test can help to differentiate between viral and bacterial infections, and this is evident from the fact that leukergy values were increased in patients with bacterial infections but were normal in those with viral infection, an observation we have previously reported (Berliner et al, unpublished observations). The increased CRP values found in the patients with viral infections in the present study agree with the findings of the previous study.24 Serum Our results support the view that aggregation of leucocytes and CRP are most probably independent indicators of the acute phase response. CRP does not seem to have a role in the development of the leucocyte aggregation, a finding corroborated by the leukergy phenomenon.
